Globular and pre-fibrillar prion aggregates are toxic to neuronal cells and perturb their electrophysiology.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbapap.2008.02.017PMID 18374666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms

  2006cited by this paper
• Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons*

  2006cited by this paper
• Elongated oligomers assemble into mammalian PrP amyloid fibrils.

  2006cited by this paper
• Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦

  2005cited by this paper
• Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration.

  2005cited by this paper
• In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).

  2005cited by this paper
• An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.

  2005cited by this paper
• Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases*

  2004cited by this paper
• Identification and characterization of a novel mouse prion gene allele

  2004cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.

  2003cited by this paper
• Heterogeneity and regulation of cellular prion protein glycoforms in neuronal cell lines

  2003cited by this paper
• Distinct profiles of PrP(d) immunoreactivity in the brain of scrapie- and BSE-infected sheep: implications for differential cell targeting and PrP processing.

  2003cited by this paper
• Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis

  2003cited by this paper
• Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

  2003cited by this paper
• Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

  2003cited by this paper
• Protein folding and misfolding

  2003cited by this paper
• Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.

  2003cited by this paper
• Binding of prion protein to lipid membranes and implications for prion conversion.

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Dependence of α-synuclein aggregate morphology on solution conditions

  2002cited by this paper
• Dependence of alpha-synuclein aggregate morphology on solution conditions.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

  2002cited by this paper
• Pathway Complexity of Prion Protein Assembly into Amyloid*

  2002cited by this paper
• Folding of Prion Protein to Its Native α-Helical Conformation Is under Kinetic Control*

  2001cited by this paper
• Prion diseases: what is the neurotoxic molecule?

  2001cited by this paper
• Folding of prion protein to its native alpha-helical conformation is under kinetic control.

  2001cited by this paper
• Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

  2001cited by this paper
• Review: history of the amyloid fibril.

  2000cited by this paper
• Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126.

  2000cited by this paper
• Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus

  2000cited by this paper
• Ultrastructural localization of prion proteins: Physiological and pathological implications

  2000cited by this paper
• Species-barrier-independent prion replication in apparently resistant species.

  2000cited by this paper
• Ultrastructural localization of prion proteins: physiological and pathological implications.

  2000cited by this paper
• In Vivo Cytotoxicity of the Prion Protein Fragment 106–126*

  2000cited by this paper
• The infrared absorption of amino acid side chains.

  2000cited by this paper
• Spontaneous action potentials initiate rhythmic intercellular calcium waves in immortalized hypothalamic (GT1-1) neurons.

  1999cited by this paper
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999cited by this paper
• Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*

  1999cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Structural Aspects of Congo Red as an Inhibitor of Protease‐Resistant Prion Protein Formation

  1998cited by this paper
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998cited by this paper
• Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments

  1998cited by this paper
• Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes

  1998cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.

  1997cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.

  1996cited by this paper
• Role of microglia and host prion protein in neurotoxicity of a prion protein fragment

  1996cited by this paper
• No propagation of prions in mice devoid of PrP.

  1994cited by this paper
• No propagation of prions in mice devoid of PrP

  1994cited by this paper
• Mice devoid of PrP are resistant to scrapie.

  1993cited by this paper
• Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

  1993cited by this paper
• Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.

  1992cited by this paper
• Action of diazepam on the voltage-dependent Na+ current. Comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil.

  1991cited by this paper
• Beware of proteins in DMSO.

  1991cited by this paper
• Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films.

  1990cited by this paper
• Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.

  1989cited by this paper

• Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease

  2021cites this paper
• Structural insight into conformational change in prion protein by breakage of electrostatic network around H187 due to its protonation

  2019cites this paper
• pH-Induced Misfolding Mechanism of Prion Protein: Insights from Microsecond-Accelerated Molecular Dynamics Simulations.

  2019cites this paper
• The cellular and pathologic prion protein.

  2018cites this paper
• Interrogating the Dimerization Interface of the Prion Protein Via Site-Specific Mutations to p-Benzoyl-L-Phenylalanine.

  2018cites this paper
• Aggregation of PrP106-126 on surfaces of neutral and negatively charged membranes studied by molecular dynamics simulations.

  2018cites this paper
• Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation.

  2017cites this paper
• Insights into Mechanisms of Chronic Neurodegeneration

  2016cites this paper
• Unraveling the Molecular Mechanism of pH-Induced Misfolding and Oligomerization of the Prion Protein.

  2016cites this paper
• Structural effects of multiple pathogenic mutations suggest a model for the initiation of misfolding of the prion protein.

  2015cites this paper
• Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.

  2015cites this paper
• The role of the misfolded prion protein in neurodegeneration

  2015cites this paper
• Rational stabilization of helix 2 of the prion protein prevents its misfolding and oligomerization.

  2014cites this paper
• Highly neurotoxic monomeric α-helical prion protein

  2012cites this paper
• Glycation promotes the formation of genotoxic aggregates in glucose oxidase

  2012cites this paper
• Increased immunohistochemical labelling for prion protein occurs in diverse neurological disorders of sheep: relevance for normal cellular PrP function.

  2012cites this paper
• Mechanisms of Cell Death in the Transmissible Spongiform Encephalopathies

  2012cites this paper
• Importance of dimerization in aggregation and neurotoxicity of Prion and [alpha]-Synuclein in prion and Parkinson's diseases

  2012cites this paper
• 4 Mechanisms of Cell Death in the Transmissible Spongiform Encephalopathies

  2012cites this paper
• The Mechanisms of Prion Disease

  2011cites this paper
• Na+/K+-ATPase Is Present in Scrapie-Associated Fibrils, Modulates PrP Misfolding In Vitro and Links PrP Function and Dysfunction

  2011cites this paper
• Deciphering the molecular details for the binding of the prion protein to main ganglioside GM1 of neuronal membranes.

  2011cites this paper
• Ribosylation Rapidly Induces α-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products

  2010cites this paper
• Phospholipid composition of membranes directs prions down alternative aggregation pathways.

  2010cites this paper
• Is PrP(106-126) fragment involved in the membrane activity of the Prion protein?

  2010cites this paper
• Stress oxydant et glycation : relation structure et activités biologiques de l'albumine in vitro et in vivo dans le cadre de la pathologie diabétique

  2009cites this paper
• Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells

  2009cites this paper